论文部分内容阅读
Reversed phase chromatographic separations are optimized for analytes containing ionizable groups by adjustment of pH of mobile phases.As it seems the pKavalues of compounds affect their retention because of the variety in their solvation.However,it is of stressful need to predict their behavior taking into account also a series of other parameters.This work focuses on the development of ten different models,using partial least squares regression,which will identify and quantify the impact of several factors in the chromatographic behavior of 104 analytes.The combined effect of their numerous characteristics is obvious since along with pH(at 2.3 and 6.2),factors such as lipophilicity,molecular volume,polar surface area and the presence of specific moieties in their structures are not diminished.On the contrary,they work increasing or counterbalancing several effects on the retention time.The models compiled can be applied to predict with reliability(R~2>0.865and Q~2>0.777)the behavior of unknown drugs.
Reversed phase chromatographic separations are optimized for analytes containing ionizable groups by adjustment of pH of mobile phases. As it seems the pKavalues of compounds affect their retention because of the variety in their solvation.However, it is of stressful need to predict their behavior taking into account also a series of other parameters. This work focuses on the development of ten different models, using partial least squares regression, which will identify and quantify the impact of several factors in the chromatographic behavior of 104 analytes. The combined effect of their massive characteristics is obvious since along with pH (at 2.3 and 6.2), factors such as lipophilicity, molecular volume, polar surface area and the presence of specific moieties in their structures are not diminished. On the contrary, they work increasing or counterbalancing several effects on the retention time.The models compiled can be applied to predict with reliability (R ~ 2> 0.865 and Q ~ 2> 0.777) the behavior of unknown drugs.